Eryaspase (ERYtech Pharma)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameEryaspase (ERYtech Pharma)
Drug Alias NameL-asparaginase loaded erythrocytes-ERYtech-PharmaErythrocyte-encapsulated L-asparaginaseAsparaginase erythrocyte encapsulated (ERYtech Pharma)GraspaEryasp +[6] 
ClassificationBiologics > Protein drugs > EnzymeCell and gene therapy > Cell therapy > Somatic cell > Erythrocyte therapy
Mechanisms of ActionAsparagine modulators
TargetsAsparagine
Therapy Area/IndicationsDiabetes Mellitus, Type 1Pancreatic NeoplasmsAdenocarcinoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSweden +[10] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesErytech Pharma
China Registration ClassN/A

Develop Information

Active CompaniesErytech Pharma
Inactive CompaniesNovocell
Active IndicationsPancreatic Neoplasms
Inactive IndicationsDiabetes Mellitus, Type 1AdenocarcinomaLeukemia, Myeloid, Acute +[4] 

Other Information

ATC CodeN/A
Related LinksN/A